Preprint · CC-BY
via bioRxiv
Molecular mechanisms underlying the modulation of T-cell proliferation and cytotoxicity by immobilized CCL21 and ICAM1
Yado, S., Dassa, B., Zoabi, R., Reich-Zeliger, S., Friedman, N., Geiger, B.
biorxiv · 2024
Abstract
BackgroundAdoptive cancer immunotherapy, using engineered T-cells, expressing chimeric antigen receptor (CARs) or autologous tumor infiltrating lymphocytes (TILs) became, in recent years, a major therapeutic approach for diverse types of cancer. However, despite the transformative potential of adoptive cancer immunotherapy, this field still faces a major challenge manifested by the complex interplay between the proliferation rate and cytotoxic capacity of effector CD8+ T cells.
MethodsWe performed integrated analysis of specific differentiation markers via flow cytometry, together with gene expression profiling to explore the molecular mechanisms through which a "synthetic immune niche" (SIN), composed of immobilized CCL21 and ICAM1, modulates the interplay between the proliferation and cytotoxic potency of effector CD8+ T cells.
ResultsOn day 3, the transcriptomic effect induced by the SIN was largely similar for both DC/OVA and anti CD3/CD28-activated cells. Cell proliferation increased and the cells exhibited high killing capacity. On day 4 and on, the proliferation/cytotoxicity phenotypes were radically "activation-specific"; The DC/OVA-activated cells lost their cytotoxic activity, which, in turn, was rescued by the SIN treatment. Upon longer incubation, the cytotoxic activity further declined, and on day7, could not be rescued by the SIN. SIN stimulation following activation with antiCD3/CD28 beads resulted in a highly proliferative phenotype with low cytotoxicity, yet the cells regained killing activity on day 7. Potential molecular regulations of the SIN effects were identified, based on transcriptomic and multispectral imaging profiling.
ConclusionsThese data indicate that cell proliferation and cytotoxicity are negatively correlated, and the interplay between them is differentially regulated by the mode of initial activation. The SIN stimulation greatly enhanced the cell expansion, following both activation modes, while maintaining high cytotoxic potency, suggesting that it could reinforce adoptive cancer immunotherapy.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- bioRxiv
- DOI
- 10.1101/2024.02.07.578152
- Canonical
- link ↗
- Fetched
- 2026-10-10 MST
Cite this
APA
S., Y., B., D., R., Z., S., R., N., F., & B., G. (2024). Molecular mechanisms underlying the modulation of T-cell proliferation and cytotoxicity by immobilized CCL21 and ICAM1. <em>biorxiv</em>. https://doi.org/10.1101/2024.02.07.578152
Vancouver
S. Y, B. D, R. Z, S. R, N. F, B. G. Molecular mechanisms underlying the modulation of T-cell proliferation and cytotoxicity by immobilized CCL21 and ICAM1. biorxiv. 2024. doi:10.1101/2024.02.07.578152.
BibTeX
@unpublished{yado2024Molecu,
title = {Molecular mechanisms underlying the modulation of T-cell proliferation and cytotoxicity by immobilized CCL21 and ICAM1},
author = {Yado, S. and Dassa, B. and Zoabi, R. and Reich-Zeliger, S. and Friedman, N. and Geiger, B.},
journal = {biorxiv},
year = {2024},
doi = {10.1101/2024.02.07.578152},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Biomedical Science 2022
Open access · CC-BY
Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend?
Cold Spring Harbor Symposia on Quantitative Biology 2005
Preprint · OA
Stem Cell Self-Renewal and Cancer Cell Proliferation Are Regulated by Common Networks That Balance the Activation of Proto-oncogenes and Tumor Suppressors
Seminars in Cancer Biology 2024
Open access · CC-BY
The interplay between cell death and senescence in cancer
Nature Communications 2021
Open access · CC-BY
Dissecting esophageal squamous-cell carcinoma ecosystem by single-cell transcriptomic analysis
MedComm 2024
Open access · CC-BY
Cellular senescence in cancer: molecular mechanisms and therapeutic targets
Aging Cell 2026
Open access · CC-BY